[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Anti-allergic Drugs Industry Research Report 2023

August 2023 | 87 pages | ID: A086F453B89DEN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Highlights

The global Anti-allergic Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-allergic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-allergic Drugs.

The Anti-allergic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-allergic Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-allergic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Sanofi
  • Johnson And Johnson
  • Merck
  • Teva
  • GlaxoSmithKline
  • Bayer
  • Sun Pharma
  • UCB Pharma
  • Yangtze River Pharmaceutical Group
  • Hainan Poly Pharm
  • Chongqing Huapont Pharmaceutical
  • Dawnrays
Product Type Insights

Global markets are presented by Anti-allergic Drugs type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Anti-allergic Drugs are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Anti-allergic Drugs segment by Type
  • Oral Drugs
  • Non-Oral Drugs
Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Anti-allergic Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Anti-allergic Drugs market.

Anti-allergic Drugs Segment by Sales Channel
  • Online
  • Offline
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Anti-allergic Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-allergic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Anti-allergic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Anti-allergic Drugs industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-allergic Drugs.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Anti-allergic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Anti-allergic Drugs by Type
  2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
  1.2.2 Oral Drugs
  1.2.3 Non-Oral Drugs
2.3 Anti-allergic Drugs by Sales Channel
  2.3.1 Market Value Comparison by Sales Channel (2018 VS 2022 VS 2029)
  2.3.2 Online
  2.3.3 Offline
2.4 Assumptions and Limitations

3 ANTI-ALLERGIC DRUGS BREAKDOWN DATA BY TYPE

3.1 Global Anti-allergic Drugs Historic Market Size by Type (2018-2023)
3.2 Global Anti-allergic Drugs Forecasted Market Size by Type (2023-2028)

4 ANTI-ALLERGIC DRUGS BREAKDOWN DATA BY SALES CHANNEL

4.1 Global Anti-allergic Drugs Historic Market Size by Sales Channel (2018-2023)
4.2 Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2018-2023)

5 GLOBAL GROWTH TRENDS

5.1 Global Anti-allergic Drugs Market Perspective (2018-2029)
5.2 Global Anti-allergic Drugs Growth Trends by Region
  5.2.1 Global Anti-allergic Drugs Market Size by Region: 2018 VS 2022 VS 2029
  5.2.2 Anti-allergic Drugs Historic Market Size by Region (2018-2023)
  5.2.3 Anti-allergic Drugs Forecasted Market Size by Region (2024-2029)
5.3 Anti-allergic Drugs Market Dynamics
  5.3.1 Anti-allergic Drugs Industry Trends
  5.3.2 Anti-allergic Drugs Market Drivers
  5.3.3 Anti-allergic Drugs Market Challenges
  5.3.4 Anti-allergic Drugs Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Anti-allergic Drugs Players by Revenue
  6.1.1 Global Top Anti-allergic Drugs Players by Revenue (2018-2023)
  6.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2018-2023)
6.2 Global Anti-allergic Drugs Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Anti-allergic Drugs Head office and Area Served
6.4 Global Anti-allergic Drugs Players, Product Type & Application
6.5 Global Anti-allergic Drugs Players, Date of Enter into This Industry
6.6 Global Anti-allergic Drugs Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Anti-allergic Drugs Market Size (2018-2029)
7.2 North America Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Anti-allergic Drugs Market Size by Country (2018-2023)
7.4 North America Anti-allergic Drugs Market Size by Country (2024-2029)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Anti-allergic Drugs Market Size (2018-2029)
8.2 Europe Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Anti-allergic Drugs Market Size by Country (2018-2023)
8.4 Europe Anti-allergic Drugs Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Anti-allergic Drugs Market Size (2018-2029)
9.2 Asia-Pacific Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Anti-allergic Drugs Market Size by Country (2018-2023)
9.4 Asia-Pacific Anti-allergic Drugs Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Anti-allergic Drugs Market Size (2018-2029)
10.2 Latin America Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Anti-allergic Drugs Market Size by Country (2018-2023)
10.4 Latin America Anti-allergic Drugs Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Anti-allergic Drugs Market Size (2018-2029)
11.2 Middle East & Africa Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Anti-allergic Drugs Market Size by Country (2018-2023)
11.4 Middle East & Africa Anti-allergic Drugs Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 Sanofi
  11.1.1 Sanofi Company Detail
  11.1.2 Sanofi Business Overview
  11.1.3 Sanofi Anti-allergic Drugs Introduction
  11.1.4 Sanofi Revenue in Anti-allergic Drugs Business (2017-2022)
  11.1.5 Sanofi Recent Development
11.2 Johnson And Johnson
  11.2.1 Johnson And Johnson Company Detail
  11.2.2 Johnson And Johnson Business Overview
  11.2.3 Johnson And Johnson Anti-allergic Drugs Introduction
  11.2.4 Johnson And Johnson Revenue in Anti-allergic Drugs Business (2017-2022)
  11.2.5 Johnson And Johnson Recent Development
11.3 Merck
  11.3.1 Merck Company Detail
  11.3.2 Merck Business Overview
  11.3.3 Merck Anti-allergic Drugs Introduction
  11.3.4 Merck Revenue in Anti-allergic Drugs Business (2017-2022)
  11.3.5 Merck Recent Development
11.4 Teva
  11.4.1 Teva Company Detail
  11.4.2 Teva Business Overview
  11.4.3 Teva Anti-allergic Drugs Introduction
  11.4.4 Teva Revenue in Anti-allergic Drugs Business (2017-2022)
  11.4.5 Teva Recent Development
11.5 GlaxoSmithKline
  11.5.1 GlaxoSmithKline Company Detail
  11.5.2 GlaxoSmithKline Business Overview
  11.5.3 GlaxoSmithKline Anti-allergic Drugs Introduction
  11.5.4 GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2017-2022)
  11.5.5 GlaxoSmithKline Recent Development
11.6 Bayer
  11.6.1 Bayer Company Detail
  11.6.2 Bayer Business Overview
  11.6.3 Bayer Anti-allergic Drugs Introduction
  11.6.4 Bayer Revenue in Anti-allergic Drugs Business (2017-2022)
  11.6.5 Bayer Recent Development
11.7 Sun Pharma
  11.7.1 Sun Pharma Company Detail
  11.7.2 Sun Pharma Business Overview
  11.7.3 Sun Pharma Anti-allergic Drugs Introduction
  11.7.4 Sun Pharma Revenue in Anti-allergic Drugs Business (2017-2022)
  11.7.5 Sun Pharma Recent Development
11.8 UCB Pharma
  11.8.1 UCB Pharma Company Detail
  11.8.2 UCB Pharma Business Overview
  11.8.3 UCB Pharma Anti-allergic Drugs Introduction
  11.8.4 UCB Pharma Revenue in Anti-allergic Drugs Business (2017-2022)
  11.8.5 UCB Pharma Recent Development
11.9 Yangtze River Pharmaceutical Group
  11.9.1 Yangtze River Pharmaceutical Group Company Detail
  11.9.2 Yangtze River Pharmaceutical Group Business Overview
  11.9.3 Yangtze River Pharmaceutical Group Anti-allergic Drugs Introduction
  11.9.4 Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2017-2022)
  11.9.5 Yangtze River Pharmaceutical Group Recent Development
11.10 Hainan Poly Pharm
  11.10.1 Hainan Poly Pharm Company Detail
  11.10.2 Hainan Poly Pharm Business Overview
  11.10.3 Hainan Poly Pharm Anti-allergic Drugs Introduction
  11.10.4 Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2017-2022)
  11.10.5 Hainan Poly Pharm Recent Development
11.11 Chongqing Huapont Pharmaceutical
  11.11.1 Chongqing Huapont Pharmaceutical Company Detail
  11.11.2 Chongqing Huapont Pharmaceutical Business Overview
  11.11.3 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Introduction
  11.11.4 Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2017-2022)
  11.11.5 Chongqing Huapont Pharmaceutical Recent Development
11.12 Dawnrays
  11.12.1 Dawnrays Company Detail
  11.12.2 Dawnrays Business Overview
  11.12.3 Dawnrays Anti-allergic Drugs Introduction
  11.12.4 Dawnrays Revenue in Anti-allergic Drugs Business (2017-2022)
  11.12.5 Dawnrays Recent Development

13 REPORT CONCLUSION


14 DISCLAIMER


LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Sales Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Anti-allergic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Anti-allergic Drugs Revenue Market Share by Type (2018-2023)
Table 7. Global Anti-allergic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Anti-allergic Drugs Revenue Market Share by Type (2024-2029)
Table 9. Global Anti-allergic Drugs Market Size by Sales Channel (2018-2023) & (US$ Million)
Table 10. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2018-2023)
Table 11. Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2024-2029) & (US$ Million)
Table 12. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2024-2029)
Table 13. Global Anti-allergic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Anti-allergic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Anti-allergic Drugs Market Share by Region (2018-2023)
Table 16. Global Anti-allergic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Anti-allergic Drugs Market Share by Region (2024-2029)
Table 18. Anti-allergic Drugs Market Trends
Table 19. Anti-allergic Drugs Market Drivers
Table 20. Anti-allergic Drugs Market Challenges
Table 21. Anti-allergic Drugs Market Restraints
Table 22. Global Top Anti-allergic Drugs Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Anti-allergic Drugs Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Anti-allergic Drugs Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Anti-allergic Drugs, Headquarters and Area Served
Table 26. Global Anti-allergic Drugs Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Anti-allergic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Anti-allergic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Anti-allergic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Anti-allergic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Anti-allergic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Anti-allergic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Anti-allergic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Anti-allergic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Anti-allergic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Anti-allergic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Anti-allergic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Sanofi Company Detail
Table 46. Sanofi Business Overview
Table 47. Sanofi Anti-allergic Drugs Product
Table 48. Sanofi Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 49. Sanofi Recent Development
Table 50. Johnson And Johnson Company Detail
Table 51. Johnson And Johnson Business Overview
Table 52. Johnson And Johnson Anti-allergic Drugs Product
Table 53. Johnson And Johnson Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 54. Johnson And Johnson Recent Development
Table 55. Merck Company Detail
Table 56. Merck Business Overview
Table 57. Merck Anti-allergic Drugs Product
Table 58. Merck Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 59. Merck Recent Development
Table 60. Teva Company Detail
Table 61. Teva Business Overview
Table 62. Teva Anti-allergic Drugs Product
Table 63. Teva Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 64. Teva Recent Development
Table 65. GlaxoSmithKline Company Detail
Table 66. GlaxoSmithKline Business Overview
Table 67. GlaxoSmithKline Anti-allergic Drugs Product
Table 68. GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 69. GlaxoSmithKline Recent Development
Table 70. Bayer Company Detail
Table 71. Bayer Business Overview
Table 72. Bayer Anti-allergic Drugs Product
Table 73. Bayer Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 74. Bayer Recent Development
Table 75. Sun Pharma Company Detail
Table 76. Sun Pharma Business Overview
Table 77. Sun Pharma Anti-allergic Drugs Product
Table 78. Sun Pharma Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 79. Sun Pharma Recent Development
Table 80. UCB Pharma Company Detail
Table 81. UCB Pharma Business Overview
Table 82. UCB Pharma Anti-allergic Drugs Product
Table 83. UCB Pharma Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 84. UCB Pharma Recent Development
Table 85. Yangtze River Pharmaceutical Group Company Detail
Table 86. Yangtze River Pharmaceutical Group Business Overview
Table 87. Yangtze River Pharmaceutical Group Anti-allergic Drugs Product
Table 88. Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 89. Yangtze River Pharmaceutical Group Recent Development
Table 90. Hainan Poly Pharm Company Detail
Table 91. Hainan Poly Pharm Business Overview
Table 92. Hainan Poly Pharm Anti-allergic Drugs Product
Table 93. Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 94. Hainan Poly Pharm Recent Development
Table 95. Chongqing Huapont Pharmaceutical Company Detail
Table 96. Chongqing Huapont Pharmaceutical Business Overview
Table 97. Chongqing Huapont Pharmaceutical Anti-allergic DrugsProduct
Table 98. Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 99. Chongqing Huapont Pharmaceutical Recent Development
Table 100. Dawnrays Company Detail
Table 101. Dawnrays Business Overview
Table 102. Dawnrays Anti-allergic DrugsProduct
Table 103. Dawnrays Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 104. Dawnrays Recent Development
Table 105. Sanofi Company Information
Table 106. Sanofi Business Overview
Table 107. Sanofi Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 108. Sanofi Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 109. Sanofi Recent Development
Table 110. Johnson And Johnson Company Information
Table 111. Johnson And Johnson Business Overview
Table 112. Johnson And Johnson Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 113. Johnson And Johnson Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 114. Johnson And Johnson Recent Development
Table 115. Merck Company Information
Table 116. Merck Business Overview
Table 117. Merck Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 118. Merck Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 119. Merck Recent Development
Table 120. Teva Company Information
Table 121. Teva Business Overview
Table 122. Teva Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 123. Teva Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 124. Teva Recent Development
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Business Overview
Table 127. GlaxoSmithKline Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 128. GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 129. GlaxoSmithKline Recent Development
Table 130. Bayer Company Information
Table 131. Bayer Business Overview
Table 132. Bayer Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 133. Bayer Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 134. Bayer Recent Development
Table 135. Sun Pharma Company Information
Table 136. Sun Pharma Business Overview
Table 137. Sun Pharma Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 138. Sun Pharma Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 139. Sun Pharma Recent Development
Table 140. UCB Pharma Company Information
Table 141. UCB Pharma Business Overview
Table 142. UCB Pharma Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 143. UCB Pharma Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 144. UCB Pharma Recent Development
Table 145. Yangtze River Pharmaceutical Group Company Information
Table 146. Yangtze River Pharmaceutical Group Business Overview
Table 147. Yangtze River Pharmaceutical Group Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 148. Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 149. Yangtze River Pharmaceutical Group Recent Development
Table 150. Hainan Poly Pharm Company Information
Table 151. Hainan Poly Pharm Business Overview
Table 152. Hainan Poly Pharm Anti-allergic Drugs Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 153. Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 154. Hainan Poly Pharm Recent Development
Table 155. Chongqing Huapont Pharmaceutical Company Information
Table 156. Chongqing Huapont Pharmaceutical Business Overview
Table 157. Chongqing Huapont Pharmaceutical Anti-allergic DrugsRevenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 158. Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 159. Chongqing Huapont Pharmaceutical Recent Development
Table 160. Dawnrays Company Information
Table 161. Dawnrays Business Overview
Table 162. Dawnrays Anti-allergic DrugsRevenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million)
Table 163. Dawnrays Revenue in Anti-allergic Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 164. Dawnrays Recent Development
Table 165. Authors List of This Report

LIST OF FIGURES

Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Anti-allergic Drugs Product Picture
Figure 5. Global Anti-allergic Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Anti-allergic Drugs Market Share by Type: 2022 VS 2029
Figure 7. Oral Drugs Product Picture
Figure 8. Non-Oral Drugs Product Picture
Figure 9. Global Anti-allergic Drugs Market Size by Sales Channel (2023-2029) & (US$ Million)
Figure 10. Global Anti-allergic Drugs Market Share by Sales Channel: 2022 VS 2029
Figure 11. Online Product Picture
Figure 12. Offline Product Picture
Figure 13. Global Anti-allergic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Anti-allergic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Anti-allergic Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Anti-allergic Drugs Market Share by Players in 2022
Figure 17. Global Anti-allergic Drugs Players, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Anti-allergic Drugs Players Market Share by Revenue in 2022
Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. North America Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Anti-allergic Drugs Market Share by Country (2018-2029)
Figure 22. United States Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Anti-allergic Drugs Market Share by Country (2018-2029)
Figure 26. Germany Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Anti-allergic Drugs Market Share by Country (2018-2029)
Figure 34. China Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Anti-allergic Drugs Market Share by Country (2018-2029)
Figure 42. Mexico Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Anti-allergic Drugs Market Share by Country (2018-2029)
Figure 46. Turkey Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. UAE Anti-allergic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Sanofi Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 50. Johnson And Johnson Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 52. Teva Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 54. Bayer Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 55. Sun Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 56. UCB Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 57. Yangtze River Pharmaceutical Group Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 58. Hainan Poly Pharm Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 59. Chongqing Huapont Pharmaceutical Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)
Figure 60. Dawnrays Revenue Growth Rate in Anti-allergic Drugs Business (2018-2023)


More Publications